From Medscape Gastroenterology

Coverage from the

International Liver Congress (ILC) 2023

June 21 - 24, 2023; Vienna, Austria/Virtual

June 21 - 24, 2023 Vienna, Austria/Virtual

ILC 2023 FMT Modifies Gut Microbiome, Reduces Ammonia in Cirrhosis Fecal microbiota transplant (FMT) promotes restoration of the gut microbiota, enzymes, and immune responses, and reduces ammonia build-up in patients with cirrhosis, a pilot study found.
Medscape Medical News, June 23, 2023
ILC 2023 'Exciting Time for NASH' With Resmetirom Phase 3 Results The 52-week results of the phase 3 MAESTRO-NASH trial show promise for resmetirom. One expert called the trial results 'real game-changer in the field of fatty liver disease.'
Medscape Medical News, June 22, 2023

Conference News

ILC 2023 Pegozafermin Improves Fibrosis in NASH in Phase 2b Study
Medscape Medical News, June 28, 2023
ILC 2023 Naltrexone Is Safe and Beneficial in AUD With Cirrhosis
Medscape Medical News, June 26, 2023
ILC 2023 Algorithm SAFE to Detect Liver Disease in General Population
Medscape Medical News, June 26, 2023

ILC 2023 FMT Modifies Gut Microbiome, Reduces Ammonia in Cirrhosis
Medscape Medical News, June 23, 2023
ILC 2023 'Exciting Time for NASH' With Resmetirom Phase 3 Results
Medscape Medical News, June 22, 2023

Medscape Gastroenterology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from ILC 2022

Low-Carb, High-Fat Diet Improves A1c, Reduces Liver Fat: Study A low-carb, high-fat diet reduced NAFLD activity score and HbA1c, and resulted in weight loss, according to a 6-month study of participants with NAFLD and type 2 diabetes.
Medscape Medical News, Jun 27, 2022
Acute Hepatitis Cases in Children Show Declining Trend Experts update the latest case numbers for acute hepatitis in children and discuss possible factors that result in the disease, namely, adenovirus and COVID-19, either separately or together.
Medscape Medical News, Jun 24, 2022
Fatty Liver Disease Drives Rise in Liver Cancer Deaths The steep increase in liver cancer deaths is due to the rising rate of NAFLD, rather than alcoholic liver disease or hepatitis B or C, and is mostly driven by the obesity and type 2 diabetes epidemics.
Medscape Medical News, Jun 27, 2022

Previous Coverage

Related Resources